Skip to main content
FENC logo
FENC
(NASDAQ)
Fennec Pharmaceuticals Inc.
$9.75-- (--)
Loading... - Market loading

Fennec Pharmaceuticals (FENC) Stock Price & Financial Analysis

Fennec Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$9.50 - $10.07
52-Week High$9.92
52-Week Low$5.65
Open$9.52
Volume288.99K
Average Volume (3M)250.20K
Market Cap278.91M
Shares Outstanding28.58M
Price to Sales (P/S)6.25
Price to Book (P/B)7.86
EV/EBITDA-30.80
Revenue (TTM)44.64M
Net Income (TTM)-9.74M
Free Cash Flow (TTM)-12.47M
EPS (TTM)$-0.34
Profit Margin-21.82%
Operating Margin-14.16%
Return on Equity (ROE)-27.46%
Debt to Equity0.00
50-Day MA$6.87
200-Day MA$7.93
52-Week Change13.24%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Fennec Pharmaceuticals

What is the current stock price for FENC?

As of the latest trading session, FENC stock trades at $9.76. The 52-week range is $5.65–$9.92, with a day range of $9.50–$10.07.

What is the P/E ratio for FENC?

The P/E ratio (Price-to-Earnings) for FENC is shown in the Key Statistics section. This valuation metric helps compare Fennec Pharmaceuticals Inc. to industry peers.

Does FENC pay dividends?

Fennec Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for FENC?

Based on 1 analyst, the consensus for FENC is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of FENC?

Fennec Pharmaceuticals's market capitalization is $278.9M, classifying it as a micro-cap company. Fennec Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.